Buy Melanotan-2: An Overview of Melanocortin Research
A factual overview of Melanotan-2 for research purposes: structure, melanocortin receptors, comparison with Afamelanotide and Bremelanotide, and notes on product quality.
Melanotan-2 is a synthetic melanocortin peptide that has been studied in research primarily for its binding to several melanocortin receptors. The central questions concern pigmentation, effects on the central nervous system, and the limits of non-selective receptor activation. For a sound overview, it helps to clearly separate preclinical data on MT-II itself from clinical data on related compounds such as Afamelanotide or Bremelanotide.
For Research Purposes Only
Melanotan-2 is not an approved drug and is not intended for human use. This article describes the state of research, mechanisms of action, and regulatory context. Sales are exclusively for research purposes.
Tanning peptide that activates melanin production in the skin. Stimulates melanocyte receptors for natural UV-free pigmentation. Also researched for appetite regulation and libido effects.
What Is Melanotan-2?
Melanotan-2 (MT-II) is a cyclic heptapeptide - a peptide built from seven amino acids with a ring structure. The sequence is:
Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
The peptide is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), a peptide derived from proopiomelanocortin (POMC). POMC-derived melanocortins are produced in the CNS and peripheral tissues; limiting their location to the hypothalamus alone would be too narrow. The development of MT-II traces back to work by Victor Hruby, Mac Hadley, and colleagues at the University of Arizona.
The cyclic structure was designed to increase stability against enzymatic degradation and to modify pharmacological activity compared to native melanocortins. MT-II has therefore been used for years as a research tool for melanocortin signaling pathways.
The Melanocortin System
To assess the research relevance of Melanotan-2, a look at the melanocortin system is necessary. It comprises five receptor subtypes (MC1R through MC5R), each fulfilling different functions in different tissues.
- MC1R - primarily in melanocytes. Involved in melanin synthesis, pigmentation, and responses to UV exposure.
- MC2R - in the adrenal cortex. The ACTH receptor, relevant for cortisol production.
- MC3R - in the CNS and peripheral tissues, among others. Involved in energy homeostasis.
- MC4R - primarily in the CNS. Important for appetite regulation, energy balance, and certain neuroendocrine effects.
- MC5R - in exocrine glands and other tissues. Its functions are still being investigated.
Receptor Profile
Melanotan-2 is most commonly described in the literature as a non-selective melanocortin agonist. Its binding to several receptor subtypes explains why both pigmentation and CNS effects have been observed in experimental systems.
State of Research
The literature on Melanotan-2 includes mechanistic studies, animal models, older human studies, and clinical context from related compounds in the same drug family. These levels should not be conflated.
Pigmentation and UV Context
A central research aspect of MT-II is the stimulation of melanocortinergic signaling pathways with influence on melanogenesis. Via MC1R-associated signaling, enhanced eumelanin production can occur in melanocytes.
Precision matters when citing clinical reference points: the often-cited work by Dorr et al. from 2004 did not study MT-II alone without UV, but an alpha-MSH analog in combination with solar UV exposure. No clean conclusion can therefore be drawn from that study that comparable pigmentation independent of UV exposure was demonstrated.
In the regulatory environment, Afamelanotide is the most relevant clinical reference point. Afamelanotide (Scenesse), a linear alpha-MSH analog, was approved by the EMA in 2014 and by the FDA in 2019 for erythropoietic protoporphyria. According to current EMA documentation, the application continues to refer to periods before and during sun-rich periods; a robustly documented EMA expansion to year-round treatment cannot be derived from this.
Sexual Function and Related Compounds
Activation of central melanocortin signaling pathways, in particular via MC4R, was also studied in animal models in connection with sexual behavior. This research line is one reason why MT-II is frequently cited together with Bremelanotide in the literature.
Careful framing is important: Bremelanotide (PT-141) is often described in the specialist literature as an analog or derivative derived from Melanotan-II; some accounts also describe it as an active or probable metabolite in the MT-II context. Bremelanotide received FDA approval on June 21, 2019 as Vyleesi for the treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women. The pooled safety presentation in the Prescribing Information refers to 1,247 premenopausal women in two placebo-controlled Phase 3 studies.
Putting Bremelanotide in Context
The approval of Bremelanotide is not evidence of approval for Melanotan-2. It does show, however, that melanocortinergic signaling pathways can have clinically relevant applications when a compound is pursued with its own development program, its own dose-finding process, and its own safety evaluation.
Appetite Regulation and Energy Balance
MC3R and MC4R signaling pathways play an important role in the central regulation of hunger and energy balance. Accordingly, MT-II is discussed in animal models and mechanistic studies in the context of anorexigenic effects as well. For interpretation, however: preclinical signaling data do not replace robust clinical evaluation.
Inflammation Modulation
Research also investigates melanocortin signaling pathways in connection with inflammatory processes. In various models, anti-inflammatory associations have been described for MC1R- and MC3R-mediated effects. This literature is primarily mechanistic and should not be read as clinical proof of benefit for MT-II.
Melanotan-I vs. Melanotan-II: What Is the Difference?
The naming regularly causes confusion. Both peptides are synthetic alpha-MSH analogs but differ substantially in structure, receptor profile, and regulatory status:
| Property | Melanotan-I (Afamelanotide) | Melanotan-II |
|---|---|---|
| Structure | Linear tridecapeptide (13 AA) | Cyclic heptapeptide (7 AA) |
| Receptor profile | Higher functional affinity toward MC1R | Non-selective agonist at multiple melanocortin receptors |
| Classification | Clinically developed compound for EPP | Research peptide without approval |
| Approval | Scenesse (EMA 2014, FDA 2019) for EPP | No approval |
| CNS effects | Not the clinical focus | Discussed in research |
Afamelanotide is an approved drug with a clearly defined indication. Melanotan-II, by contrast, is not approved and is classified primarily as a research peptide. The shared origin in the melanocortin context does not mean that efficacy, safety, or regulatory status are transferable.
Safety Aspects in Research
A factual assessment of Melanotan-2 must also address safety questions. The non-selective receptor activation in particular is one reason why experimental effects are not automatically therapeutically meaningful or safe.
Safety Situation
The literature on MT-II and related melanocortin agonists describes, among other things, nausea, flushing, fatigue, changes in pigmentation, and cardiovascular effects. With unapproved products, additional risks arise from unclear concentration, contamination, and lack of standardization.
For dermatological questions, the data must be interpreted cautiously. Case reports describe changes in existing nevi during or after exposure to unregulated melanocortin agonists. Such reports do not prove causality but represent a relevant risk indicator.
The review by Boehm et al. published in 2025 in the Journal of the European Academy of Dermatology and Venereology describes that long-term MC1R activation has not so far been associated with increased melanoma incidence. At the same time, the authors emphasize that no prevention of melanoma may be derived from this, and that UV protection and dermatological monitoring, especially in at-risk individuals, remain appropriate.
Quality Criteria When Buying
When Melanotan-2 is procured for research purposes, analytical evidence is more important than promotional language.
Purity and Analytics
Meaningful analytical data per batch includes HPLC chromatograms, mass spectrometry for identity verification, and a clearly assignable Certificate of Analysis.
What to look for:
- Batch-specific HPLC data rather than blanket purity claims
- Mass spectrometry to plausibilize identity
- Third-party laboratory analytics, where available
- Transparent COAs with date, batch reference, and measured values
Product context: PeptidesDirect offers Melanotan-2 as a research-grade product. The deposited analytical data should carry more weight in the evaluation than statements about shipping, availability, or advertising claims.
Storage and Handling
Melanotan-2 is typically sold commercially as a lyophilized powder. For unapproved products, storage, reconstitution, and shelf life should not be assumed out of habit but should always follow the concrete manufacturer documentation and the respective research protocol.
Practical Principle
Without reliable batch- or manufacturer-specific documentation, very precise statements about temperature, solvent, and stability after reconstitution are not well-founded. Research work should therefore only draw on documented specifications from the relevant product and protocol.
Regardless of specific instructions, it generally holds that light, moisture, temperature fluctuations, and repeated handling can affect peptide stability. Accordingly, every laboratory practice should be documented and aligned with the available product documentation.
Frequently Asked Questions
Order Melanotan-2 for Research
Anyone procuring Melanotan-2 for research purposes should focus above all on reliable analytics, clear product documentation, and a clean separation between research product and pharmaceutical-grade standards.
Tanning peptide that activates melanin production in the skin. Stimulates melanocyte receptors for natural UV-free pigmentation. Also researched for appetite regulation and libido effects.